45 results
6-K
EX-99.1
GNFT
Genfit
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
nature of the medicine concerned. There can be no guarantees a medicine will receive the necessary regulatory approvals or that the medicine will prove
6-K
EX-99.1
GNFT
Genfit
13 Nov 23
Current report (foreign)
4:30pm
will be sufficient to demonstrate the safe and effective nature of the medicine concerned. There can be no guarantees a medicine will receive
6-K
EX-99.1
d6d03
26 Sep 23
GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
4:10pm
6-K
EX-99.1
k20nk6mmvcxj6z
20 Sep 23
Current report (foreign)
4:44pm
6-K
EX-99.1
pn8d5 odt3a
30 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.2
kbif7816jdp ii
19 Apr 23
Current report (foreign)
4:10pm
F-3
egr49xolb6c
18 Apr 23
Shelf registration (foreign)
2:33pm
6-K
EX-99.1
1nc9rcz
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
EX-99.2
yzjh 5omf8360e0s
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm